Literature DB >> 25499348

Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients.

Tommy Andersson1, Anders Magnuson2, Ing-Liss Bryngelsson3, Ole Frøbert4, Karin M Henriksson5, Nils Edvardsson6, Dritan Poçi4.   

Abstract

BACKGROUND: Previous studies of patients with "lone" and "idiopathic" atrial fibrillation (AF) have provided conflicting evidence concerning the development, management and prognosis of this condition.
METHODS: In this nation-wide, retrospective, cohort study, we studied patients diagnosed with incidental AF recorded in national Swedish registries between 1995 and 2008. Controls were matched for age, sex and calendar year of the diagnosis of AF in patients. All subjects were free of any in-hospital diagnosis from 1987 and until patients were diagnosed with AF and also free of any diagnosis within one year from the time of inclusion. Follow-up continued until 2009. We identified 9519 patients (31% women) and 12,468 matched controls.
RESULTS: Relative risks (RR) versus controls for stroke or transient ischemic attack (TIA) in women were 19.6, 4.4, 3.4 and 2.5 in the age categories <55, 55-64, 65-74 and 75-85, years respectively. Corresponding figures for men were 3.4, 2.5, 1.7 and 1.9. RR for heart failure were 6.6, 6.6, 6.3 and 3.8 in women and 7.8, 4.6, 4.9 and 2.9 in men. All RR were statistically significant with p < 0.01. RR for myocardial infarction and all-cause mortality were statistically significantly increased only in the two oldest age categories in women and 65-74 years in men.
CONCLUSIONS: Patients with AF and no co-morbidities at inclusion had at least a doubled risk of stroke or TIA and a tripled risk of heart failure, through all age categories, as compared to controls. Women were at higher RR of stroke or TIA than men.
Copyright © 2014. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Atrial fibrillation; Cardiovascular morbidity; Cohort; Mortality; Nationwide

Mesh:

Year:  2014        PMID: 25499348     DOI: 10.1016/j.ijcard.2014.09.092

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

1.  Atrial fibrillation in organ transplant recipients: only a marker of the underlying disease?

Authors:  Francesca Innocenti; Riccardo Pini
Journal:  Intern Emerg Med       Date:  2018-11-29       Impact factor: 3.397

Review 2.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.

Authors:  Darae Ko; Faisal Rahman; Renate B Schnabel; Xiaoyan Yin; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

3.  The gap between indicated and prescribed stroke prevention therapies in a high-risk geriatric population.

Authors:  Mohammed Shurrab; Eugene Crystal; Denis O'Donnell; Hrishikesh Navare; Paula Neves; Rasha Khatib; Ilan Lashevsky; David Newman
Journal:  J Interv Card Electrophysiol       Date:  2017-01-16       Impact factor: 1.900

4.  Patients without comorbidities at the time of diagnosis of atrial fibrillation: causes of death during long-term follow-up compared to matched controls.

Authors:  Tommy Andersson; Anders Magnuson; Ing-Liss Bryngelsson; Ole Frøbert; Karin M Henriksson; Nils Edvardsson; Dritan Poçi
Journal:  Clin Cardiol       Date:  2017-08-25       Impact factor: 2.882

5.  Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.

Authors:  Charles D Nicoli; Wesley T O'Neal; Emily B Levitan; Matthew J Singleton; Suzanne E Judd; George Howard; Monika M Safford; Elsayed Z Soliman
Journal:  Heart       Date:  2021-05-24       Impact factor: 5.994

Review 6.  Epidemiology, diagnosis, and management of atrial fibrillation in women.

Authors:  Daniela Poli; Emilia Antonucci
Journal:  Int J Womens Health       Date:  2015-06-11

Review 7.  Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis.

Authors:  Vidar Ruddox; Irene Sandven; John Munkhaugen; Julie Skattebu; Thor Edvardsen; Jan Erik Otterstad
Journal:  Eur J Prev Cardiol       Date:  2017-06-15       Impact factor: 7.804

Review 8.  Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies.

Authors:  Connor A Emdin; Christopher X Wong; Allan J Hsiao; Douglas G Altman; Sanne Ae Peters; Mark Woodward; Ayodele A Odutayo
Journal:  BMJ       Date:  2016-01-19

9.  Gender-related Differences in Management of Nonvalvular Atrial Fibrillation in an Asian Population.

Authors:  Jung Myung Lee; Tae Hoon Kim; Myung Jin Cha; Junbeom Park; Jin Kyu Park; Ki Woon Kang; Jaemin Shim; Jae Sun Uhm; Jun Kim; Hyung Wook Park; Young Soo Lee; Eue Keun Choi; Chang Soo Kim; Boyoung Joung; Jin Bae Kim
Journal:  Korean Circ J       Date:  2018-06       Impact factor: 3.243

Review 10.  Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms.

Authors:  Francesco Violi; Elsayed Z Soliman; Pasquale Pignatelli; Daniele Pastori
Journal:  J Am Heart Assoc       Date:  2016-05-20       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.